Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue-Photodynamic Therapy for Burn Wound Infection
NCT07494773Phase 1Not yet recruiting
- Sponsor
- University of Oklahoma
- Start
- Jun 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of methylene blue in burn wound infection (2 arms), sponsored by University of Oklahoma. Primary endpoint: Wound Healing Trajectory Measured by Digital Planimetry. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
methylene blue
03
Conditions
burn wound infection
Beyond the preview
Go deeper on NCT07494773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07494773.